Iambic Therapeutics, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filing history at a glance
The reported offering amount was $49,999,996 in the Apr 8, 2026 filing and $66,500,000 in the Sep 9, 2026 filing. The two records may concern different offerings. All 3 stored filings from Nov 21, 2025 to Sep 9, 2026 are original notices.
through Sep 9, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Apr 8, 2026 · D | Sep 9, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $49,999,996 | $66,500,000 | $16,500,004 |
| Reported amount sold | $27,769,668 | $65,965,000 | $38,195,332 |
| Reported investor count | — | 16 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001997038-26-000001 · Later SEC source: 0001997038-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $66,500,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $65,965,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20262 filings
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (3)
-
0001997038-26-000002D · Sep 9, 2026 · BiotechnologyOffering: $66,500,000Sold: $65,965,000
Compared with 0001997038-26-000001:
- Reported offering amount: $49,999,996 → $66,500,000
- Reported amount sold: $27,769,668 → $65,965,000
- Reported investor count: Unavailable → 16
-
0001997038-26-000001D · Apr 8, 2026 · BiotechnologyOffering: $49,999,996Sold: $27,769,668
Compared with 0001997038-25-000002:
- Reported offering amount: $124,999,970 → $49,999,996
- Reported amount sold: $99,269,270 → $27,769,668
-
0001997038-25-000002D · Nov 21, 2025 · BiotechnologyOffering: $124,999,970Sold: $99,269,270